Skip to main content
Overview
News
Events & Presentations
Stock Information
Stock Quote
Stock Chart
Historical Stock Quote
Investment Calculator
Financials
Form 8937
SEC Filings
Governance
Corporate Governance
Management Team
Resources
Information Request Form
Investor Email Alerts
Site Search
Search query
Overview
News
Events & Presentations
Stock Information
Stock Quote
Stock Chart
Historical Stock Quote
Investment Calculator
Financials
Form 8937
SEC Filings
Governance
Corporate Governance
Management Team
Resources
Information Request Form
Investor Email Alerts
Search query
News
Overview
News
Events & Presentations
Stock Information
Stock Quote
Stock Chart
Historical Stock Quote
Investment Calculator
Financials
Form 8937
SEC Filings
Governance
Corporate Governance
Management Team
Resources
Information Request Form
Investor Email Alerts
Normal
Press release year list
2022
2021
2020
2019
2018
04/21/2022
Brooklyn ImmunoTherapeutics Announces Establishment of New Research and Development Facility for Advancement of Engineered Cellular Medicines
04/15/2022
Brooklyn ImmunoTherapeutics Announces Fourth Quarter and Full Year 2021 Financial Results
03/09/2022
Brooklyn ImmunoTherapeutics Announces Closing of $12 Million Private Placement
03/07/2022
Brooklyn ImmunoTherapeutics Announces $12 Million Private Placement
01/20/2022
Brooklyn ImmunoTherapeutics Welcomes Erin S. Enright and Heather B. Redman to Its Board of Directors
01/13/2022
Brooklyn ImmunoTherapeutics Provides Update on Regenerative Medicine Intellectual Property Portfolio